Semarion
Drug Discovery
- Website
- https://www.semarion.com/
- Membership category
- Emerging Y3
14 Vawser Way, Cambridge, CB2 0AR, United Kingdom
Semarion at a glance
Our SemaCyte® steerable microcarriers bring adherent cells into suspension for a paradigm shift in cell screening.
About Semarion
Semarion operates at the edge of the physical and life sciences by using microchip industry materials and techniques to transform cell-based research. The rate of data output during drug discovery work is often limited by the adherent nature of cell models. Our solution is simple: keep colonies of cells attached to a surface, but now bring this surface into suspension. We make this possible with our SemaCyte® cell assaying microcarrier platform. These materials are ultra-miniaturized, steerable wells which turn adherent cells into liquid reagents. With our SemaCytes® we can accelerate, miniaturize, and multiplex cell assays to drive 10x gains in drug screening applications such as SAR studies, cell panel screening, or patient-derived cell work. Our platform can seamlessly integrate with existing workflows, while also enabling novel assay methodologies. Our mission is to revolutionize in vitro research on cell models to help create better medicines, faster.
